13.07.2015
- In another move to sharpen its focus on oncology, diabetes and respiratory disorders, AstraZeneca has announced it is selling all non-US rights for Entocort, a treatment for Crohn...
26.06.2015
- ADC Therapeutics announced the appointment of Dr Chris Martin as its CEO. Dr Martin was co-founder of Spirogen and its CEO leading up to the sale of Spirogen to MedImmune, the...
11.06.2015
- AstraZeneca is mulling whether to independently pursue the developmental psoriasis drug brodalumab after its partner Amgen’s withdrawal from the project in May, Pascal Soriot...
08.06.2015
- On June 2, The International Society for Pharmaceutical Engineering (ISPE) formally appreciated its 2015 Facility of the Year Awards (FOYA) category winners at a banquet in...
29.05.2015
- Speculation that US pharmaceutical giant Pfizer, after a failed attempt last year to take over AstraZeneca, has its sights on GlaxoSmithKline (GSK) are gaining renewed attention...
24.04.2015
- Dr. Giorgio Bruno has been appointed General Manager of Recipharm Italia. In this role, he will serve as CEO for all of Recipharm's Italian operating companies. Dr. Bruno has long...
13.03.2015
- Both European and US pharmaceutical industry players are highly research-oriented and possess very diversified portfolios. While each country has its national champions, Swiss...
04.03.2015
- AstraZeneca has completed its acquisition of the rights to Actavis' branded respiratory business in the US and Canada. The UK-Swedish drugmaker said the buy strengthens its...